INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Published:2007-04 Issue:4 Volume:27 Page:439-444
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

EMERSON M VAUGHN,LAUER ANDREAS K.,FLAXEL CHRISTINA J.,WILSON DAVID J.,FRANCIS PETER J.,STOUT J TIMOTHY,EMERSON GEOFFREY G.,SCHLESINGER THOMAS K.,NOLTE SUSAN K.,KLEIN MICHAEL L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference12 articles.

1. Prevalence of age-related macular degeneration in the United States.;Arch Ophthalmol,2004

2. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the Multi-ethnic Study of Atherosclerosis.;Klein;Arch Ophthalmol,2006

3. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial.;Arch Ophthalmol,1982

4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macula degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2.;Arch Ophthalmol,2001

5. The role of vascular endothelial growth factor in ocular health and disease.;Adamis;Retina,2005

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Safety, Effectiveness and Prognostic Factors of Intravitreal Avastin (Bevacizumab) Injection for the Treatment of Macular Edema at the University of Gondar Tertiary Eye Care and Training Center, NW Ethiopia;2024-07-10

2. Effect of adalimumab on experimental corneal neovascularization model;International Ophthalmology;2023-04-04

3. Controversies and Disparities in the Management of Age-Related Macular Degeneration;Seminars in Ophthalmology;2023-01-05

4. Visual Outcome of Anti-Vascular Endothelial Growth Factor Injection at the University of Gondar Hospital Tertiary Eye Care and Training Centre, North-West Ethiopia;2022-08-24

5. Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration;Ophthalmology Journal;2021-06-09